Inhibition of calcium accumulatory by the sarcoplasmic reticulum: A putative mechanism for the cardiotoxicity of adriamycin

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 211-214

  Halili Rutman, Irit ^a   Hershko, Chaim ^b   Link, Gavriela ^b   Rutman, Avram J ^a   Shainberg, Asher ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Adriamycin; Calcium accumulation; Cardiotoxicity; Iron; Reticulum; Sarcoplasmic

Indexed keywords

DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; CALCIUM; FERRIC ION;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CARDIOTOXICITY; CELL CULTURE; CONTROLLED STUDY; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; ANIMAL; DRUG EFFECT; HEART; HEART MITOCHONDRION; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CALCIUM; CELLS, CULTURED; DOXORUBICIN; FERRIC COMPOUNDS; HEART; MITOCHONDRIA, HEART; OXIDATION-REDUCTION; RATS; SARCOPLASMIC RETICULUM;

EID: 0030612394     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00108-1     Document Type: Article

References (13)

1. Martindale W, The Extra Pharmacopoeia. 30th ed. pp. 475-477, The Pharmaceutical Press, London, 1993.
2. Olson HM, Young DM, Prieur AF, Roy LE and Reagen RL, Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits. Am J Pathol 77: 439-445, 1974.
3. Pessah IN, Schiedt MJ, Shalaby MA and Gidi SN, Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy. Toxicology 72: 189-206, 1992.
4. Olson R and Mushlin S, Doxorubicin cardiocoxicity: Analysis of prevailing hypotheses. FASEB J 4: 3076-3086, 1990.
5. Olson RD, Boerth CR, Gerber GJ and Nies SA, Mechanism of adriamycin cardiocoxicity: evidence for oxidative stress. Life Sciences 29: 1393-1401, 1981.
6. Singal K, Siveski-Iliskovic N, Hill M, Thomas P, Li TH and Li TI, Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27: 1055-1063, 1995.
7. Hershko C, Link G, Tzahor M, Kaltwasser JP, Athias P, Grynberg A and Pinson A, Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. J Lab Clin Med 122: 245-251, 1993.
8. 3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin. Cancer Res 50: 2307-2310, 1990.
9. El Ani D, Kenneth AJ and Shainberg A, Characterization of adenosine receptors in intact cultured heart cells. Biochem Pharmacol 48: 727-735, 1994.
10. Weinstein L, Shainberg A, Brik H and Rotmensch H, Characterization of sarcoplasmic reticulum in skinned muscle cultures. J Cell Physiol 148: 124-132, 1991.
11. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
12. Rohn TT, Hinds TR and Vincenzi FF, Ion transport ATPases as targets for free radical damage. Protection by an amino-steroid of the Ca-pump ATPase and Na/K pump ATPase of human red blood cell membranes. Biochem Pharmacol 46: 525-534, 1993.
13. Suzuki YJ and Ford GD, Inhibition of Ca-ATPase of vascular smooth sarcoplasmic reticulum by reactive oxygen intermediates. Am J Physiol 261: H568-H574, 1991.